[LXRX] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- 7.96%
YoY- -12.47%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 28 39 35 37 14 23 234 -75.62%
PBT -30,494 -23,387 -24,587 -23,476 -25,611 -23,122 -18,067 41.62%
Tax 216 292 580 96 -14 -90 19 403.35%
NP -30,710 -23,679 -25,167 -23,572 -25,611 -23,122 -18,067 42.29%
Tax Rate - - - - - - - -
Total Cost 30,738 23,718 25,202 23,609 25,625 23,145 18,301 41.16%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin -109,678.57 -60,715.38 -71,905.71 -63,708.11 -182,935.71 -100,530.43 -7,720.94 483.71%
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -0.16 -0.14 -0.17 -0.16 -0.17 -0.16 -0.13 14.80%
EPS Diluted -0.16 -0.14 -0.17 -0.16 -0.17 -0.16 -0.13 14.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.